OPA1 (Optic Atrophy Protein 1), a mitochondria-shaping protein, participates in resistance against gefitinib in a lung adenocarcinoma cell line [22] and cisplatin in NSCLC [23]. This evidence concerns the gene OPA1 and lung adenocarcinoma.